SIGA Reports Financial Results for Three Months Ended March 31, 2024
May 07, 2024 16:05 ET
|
SIGA Technologies Inc.
Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 MillionCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies,...
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024 16:05 ET
|
Caribou Biosciences, Inc.
-- Advancing CB-010 ANTLER Phase 1 trial in 2L LBCL; initial dose expansion data to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting -- -- Expanding into...
Veeco Reports First Quarter 2024 Financial Results
May 07, 2024 16:05 ET
|
Veeco Instruments Inc.
First Quarter 2024 Highlights: Revenue of $174.5 million, compared with $153.5 million in the same period last yearGAAP net income of $21.9 million, or $0.37 per diluted share, compared with $8.7...
Open Lending Reports First Quarter 2024 Financial Results
May 07, 2024 16:05 ET
|
Open Lending Corporation
AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions...
The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit
May 07, 2024 16:05 ET
|
Toi Management, LLC
CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel...
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
May 07, 2024 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing...
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
May 07, 2024 16:05 ET
|
Taysha Gene Therapies, Inc.
DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the...
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
May 07, 2024 16:05 ET
|
Lyell Immunopharma, Inc
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies...
Ocular Therapeutix™ Reports First Quarter 2024 Results
May 07, 2024 16:05 ET
|
Ocular Therapeutix, Inc.
Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First Subjects...
Oculis Publishes Invitation to the Annual General Meeting
May 07, 2024 16:05 ET
|
Oculis Holding AG
Zug, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq Global Market: OCS) (“Oculis”), has published the invitation to the 2024 Annual General Meeting, which will be held on...